A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease
Abstract
Cerebrospinal fluid (CSF) tau and beta-amyloid levels in chronic traumatic encephalopathy (CTE), a disease which can be clinically indistinguishable from Alzheimer’s disease (AD), are largely unknown. We examined postmortem CSF analytes among participants with autopsy confirmed CTE and AD.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Feb 09, 2022
- Source ID
- 10.1186/s13195-022-00976-y
Entities
People
- Alexandra Geada
- Andrew E. Budson
- Ann C. Mckee
- Bertrand R. Huber
- Brigid Dwyer
- Douglas I. Katz
- Gaoyuan Meng
- Jesse Mez
- Jonathan D Cherry
- Katherine W. Turk
- Lee E. Goldstein
- Michael L Alosco
- Neil W. Kowall
- Raymond Nicks
- Robert A. Stern
- Robert C. Cantu
- Sarah Daley
- Thor D Stein
- Victor E. Alvarez
- Weiming Xia
- Yorghos Tripodis
Organizations
- Alzheimer's Association
- National Heart, Lung, and Blood Institute
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
- United States Department of Defense
- United States Department of Veterans Affairs